Meridian Continues Its Fight Against Tropical Diseases by Introducing the Most Comprehensive Menu of Antigens and Antibodies for Diagnostic Applications
CINCINNATI, May 04, 2017 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the most comprehensive product offering of tropical disease biologicals intended for the development and manufacture of point-of-care (POC) diagnostic tests. This product menu from Meridian Life Science, Inc., a wholly-owned subsidiary of Meridian Bioscience, Inc., of over 150 highest quality biologicals consisting […]